BioCryst Appoints David W. Jenkins as Chief Scientific Officer
Go back to BioCryst Appoints David W. Jenkins as Chief Scientific Officer| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.29 +0.19 (2.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.10 | 52 Week High | $10.98 | |||
| Open | $8.99 | 52 Week Low | $1.63 | |||
| Day High | $9.32 | P/E | N/A | |||
| Day Low | $8.95 | EPS | $-0.68 | |||
| Volume | 3,268,874 | |||||
